{"id":"https://openalex.org/W214908574","doi":"https://doi.org/10.1007/s007020200037","title":"Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.","display_name":"Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W214908574","doi":"https://doi.org/10.1007/s007020200037","mag":"214908574","pmid":"https://pubmed.ncbi.nlm.nih.gov/11956965"},"language":"en","primary_location":{"id":"doi:10.1007/s007020200037","doi":"https://doi.org/10.1007/s007020200037","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s007020200037","pdf_url":null,"source":{"id":"https://openalex.org/S1737980","display_name":"Journal of Neural Transmission","issn_l":"0300-9564","issn":["0300-9564","1435-1463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neural Transmission","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022761689","display_name":"Piotr Tutka","orcid":"https://orcid.org/0000-0001-5731-4295","observed_orcids":["https://orcid.org/0000-0001-5731-4295"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"P. Tutka","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Medical University of Lublin, Poland. tutkap@itsa.ucsf.edu","Department of Pharmacology and Toxicology, and, , PL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Medical University of Lublin, Poland. tutkap@itsa.ucsf.edu","institution_ids":["https://openalex.org/I121032520"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology, and, , PL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009737999","display_name":"Jarogniew Jacek \u0141uszczki","orcid":"https://orcid.org/0000-0002-3059-0393","observed_orcids":["https://orcid.org/0000-0002-3059-0393"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"J. \u0141uszczki","raw_affiliation_strings":["Department of Pathophysiology, Medical University of Lublin, Lublin, Poland, PL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology, Medical University of Lublin, Lublin, Poland, PL","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111703551","display_name":"Zdzislaw Kleinrok","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z. Kleinrok","raw_affiliation_strings":["Department of Pharmacology and Toxicology, and, , PL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, and, , PL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064879004","display_name":"Katarzyna Arent","orcid":"https://orcid.org/0000-0002-7671-1066","observed_orcids":["https://orcid.org/0000-0002-7671-1066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Arent","raw_affiliation_strings":["Department of Pharmacology and Toxicology, and, , PL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, and, , PL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011949046","display_name":"Marian Wielosz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Wielosz","raw_affiliation_strings":["Department of Pharmacology and Toxicology, and, , PL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, and, , PL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.5198,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.80570213,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"109","issue":"4","first_page":"455","last_page":"466"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/molsidomine","display_name":"molsidomine","score":1.0},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pentylenetetrazole-induced-seizures","display_name":"pentylenetetrazole-induced seizures","score":0.9240000247955322},{"id":"https://openalex.org/keywords/anticonvulsant-drug-interactions","display_name":"anticonvulsant drug interactions","score":0.8259999752044678},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8610000014305115},{"id":"https://openalex.org/keywords/nitric-oxide-synthase","display_name":"nitric oxide synthase","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6510000228881836},{"id":"https://openalex.org/keywords/clonic-seizures","display_name":"clonic seizures","score":0.6389999985694885},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8140000104904175},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.7409999966621399},{"id":"https://openalex.org/keywords/ethosuximide","display_name":"ethosuximide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":1.0}],"concepts":[{"id":"https://openalex.org/C2780773033","wikidata":"https://www.wikidata.org/wiki/Q408132","display_name":"Molsidomine","level":3,"score":0.9954113960266113},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6824348568916321},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6118327975273132},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5345842838287354},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5225586295127869},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5168588757514954},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.42084386944770813},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.3771369159221649},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23529967665672302},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05227154493331909}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008981","descriptor_name":"Molsidomine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008981","descriptor_name":"Molsidomine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010433","descriptor_name":"Pentylenetetrazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s007020200037","doi":"https://doi.org/10.1007/s007020200037","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s007020200037","pdf_url":null,"source":{"id":"https://openalex.org/S1737980","display_name":"Journal of Neural Transmission","issn_l":"0300-9564","issn":["0300-9564","1435-1463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neural Transmission","raw_type":"journal-article"},{"id":"pmid:11956965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11956965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neural transmission (Vienna, Austria : 1996)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1969505170","https://openalex.org/W1971680727","https://openalex.org/W1987460794","https://openalex.org/W2000832826","https://openalex.org/W2003794997","https://openalex.org/W2009830428","https://openalex.org/W2015954016","https://openalex.org/W2016230171","https://openalex.org/W2021857511","https://openalex.org/W2025652380","https://openalex.org/W2031833127","https://openalex.org/W2037997999","https://openalex.org/W2057479349","https://openalex.org/W2058903844","https://openalex.org/W2059821606","https://openalex.org/W2060878473","https://openalex.org/W2084715465","https://openalex.org/W2085429609","https://openalex.org/W2162500611","https://openalex.org/W2412638650","https://openalex.org/W2414751919","https://openalex.org/W3142053745"],"related_works":["https://openalex.org/W2400274032","https://openalex.org/W2412638650","https://openalex.org/W2162500611","https://openalex.org/W2057479349","https://openalex.org/W2040043036","https://openalex.org/W4231222972","https://openalex.org/W2121280612","https://openalex.org/W3011779654","https://openalex.org/W3191626752","https://openalex.org/W3089487877"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}